Cue Biopharma, Inc. (FRA:1UC)
Germany · Delayed Price · Currency is EUR 0.2400
-0.0940 (-28.14%)
At close: Dec 19, 2025
Cue Biopharma Market Cap
Cue Biopharma has a market cap or net worth of €18.02 million as of December 22, 2025. Its market cap has decreased by -70.92% in one year.
Market Cap
18.02M
Enterprise Value
5.86M
Revenue
6.05M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.24
Market Cap Chart
Since January 2, 2018, Cue Biopharma's market cap has decreased from 187.83M to 18.02M, a decrease of -90.41%. That is a compound annual growth rate of -25.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 18.02M | -72.98% |
| Dec 31, 2024 | 66.70M | -38.11% |
| Dec 29, 2023 | 107.77M | -6.11% |
| Dec 30, 2022 | 114.78M | -63.66% |
| Dec 31, 2021 | 315.86M | 2.00% |
| Dec 31, 2020 | 309.65M | -4.80% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 2, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 243.17B |
| Siemens Aktiengesellschaft | 183.73B |
| Allianz SE | 148.10B |
| Deutsche Telekom AG | 130.23B |
| Siemens Energy AG | 102.77B |
| Rheinmetall AG | 71.55B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 71.18B |
| Deutsche Bank Aktiengesellschaft | 62.85B |